Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

123.97
Delayed Data
As of Apr 27
 -1.23 / -0.98%
Today’s Change
94.42
Today|||52-Week Range
127.64
+7.10%
Year-to-Date

Today’s Trading

Previous close125.20
Today’s open122.48
Day’s range122.12 - 124.98
Volume4,638,696
Average volume (3 months)3,859,703
Market cap$97.4B
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+21.46%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+22.70%
P/E ratio49.8
Price/Sales8.51
Price/Book14.77

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.10+0.25%
ABBVAbbVie+1.03+1.58%
----
LLYEli Lilly and Co+0.37+0.46%
Data as of 4:02pm ET, 04/27/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.77
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts